The time is now: Achieving FH paediatric screening across Europe – The Prague Declaration

• Author(s): Bedlington, Nicole ; Abifadel, Marianne ; Beger, Birgit ; Bourbon, Mafalda ; Bueno, Héctor ; Ceska, Richard ; Cillíková, Kristýna ; Cimická, Zdenka ; Daccord, Magdalena ; Beaufort, Carine de ; Dharmayat, Kanika I. ; Ference, Brian A. ; Freiberger, Tomáš ; Geanta, Marius ; Gidding, Samuel S. ; Grošelj, Urh ; Halle, Martin ; Johnson, Neil ; Novakovic, Tanja ; Májek, Ondrej ; Pallidis, Athanasios ; Peretti, Noel ; Pinto, Fausto J. ; Ray, Kausik Kosh ; Rees, Bleddyn ; Reeve, John ; Reiner, Željko ; Santos, Raul D. ; Schunkert, Heribert ; Šikonja, Jaka ; Sokolovic, Milka ; Tokgözoglu, Lale ; Vrablík, Michal ; Wiegman, Albert ; Gutiérrez-Ibarluzea, Iñaki
• Date: 2022
• Persistent ID: http://hdl.handle.net/10400.18/8466
• Origin: Repositório Científico do Instituto Nacional de Saúde
• Subject(s): Familial Hypercholesterolaemia; FH; Screening; Children; Cardiovascular Disease; CVD; Prevention; Cardiovascular Health; CVH; Declaration; Public Health; Health Systems; EU; Europe; EU Best Practice; Implementation; Doenças Cardio e Cérebro-vasculares
• Document Type: Journal article
• Language: English
• Contributor(s): Repositório Científico do Instituto Nacional de Saúde

Description

Familial Hypercholesterolaemia (FH) is severely under-recognized, under-diagnosed and under-treated in Europe, leading to a significantly higher risk of premature cardiovascular diseases in those affected. FH stands for inherited, very high cholesterol and affects 1:300 individuals regardless of their age, race, sex, and lifestyle, making it the most common inherited metabolic disorder and a non-modifiable cardiovascular disease risk factor in the world.